14 completed. 14 Phase 2, 5 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Completed 14 |
| Phase 1 | 5 | Completed 5 |
| Phase 3 | 1 | Completed 1 |
Follow Chronic Pancreatitis: new trials by email Literature Review of Chronic Pancreatitis trials Research Report on Chronic Pancreatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis Lidocaine IV - Pancreatic Cancer, Chronic Pancreatitis | Phase 2 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 30 | 2021-01-14 | 2023-10-02 |
| Spinal Cord Stimulation for the Treatment of Pain in Chronic Pancreatitis Spinal Cord Stimulation, Sham - Chronic Pancreatitis, Chronic Pain | Phase 2 | Completed | Aalborg University Hospital | 16 | 2020-11-01 | 2024-01-30 |
| Trial of Indomethacin in Chronic Pancreatitis Indomethacin, Placebo, Endoscopy for Pancreatic Function Testing - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Mayo Clinic | 27 | 2020-07-15 | 2024-09-04 |
| Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT Hydroxychloroquine, Placebo - Chronic Pancreatitis, Insulin Dependent Diabetes | Phase 2 | Completed | The Cleveland Clinic | 9 | 2017-10-03 | 2022-04-08 |
| A Phase IIa Study With Escalating Dose of MS1819-SD MS1819-SD - Chronic Pancreatitis, Distal Pancreatectomy | Phase 2 | Completed | AzurRx SAS | 11 | 2017-01-27 | 2018-09-28 |
| Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis Prolastin-C, Placebo - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 48 | 2017-01-11 | 2023-06-29 |
| Fat Malabsorption in Chronic Pancreatitis Creon36™ - Chronic Pancreatitis | Phase 2 | Completed | Children's Hospital of Philadelphia | 48 | 2016-10-13 | 2019-05-03 |
| A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 NI-03, Placebo - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Kangen Pharmaceuticals, Inc | 264 | 2016-02-24 | 2022-12-16 |
| Carbon Monoxide-Saturated Medium for Islet Isolation Carbon monoxide-bubbled mediums - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 16 | 2015-01-01 | 2019-01-04 |
| Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain Namisol, Diazepam - Cannabinoid, Tetrahydrocannabinol | Phase 2 | Completed | Radboud University Medical Center | 24 | 2011-10-01 | 2013-07-09 |
| Secretin Infusion for Pain Due to Chronic Pancreatitis Human Secretin - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | ChiRhoClin, Inc. | 12 | 2010-12-01 | 2016-03-09 |
| BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala) - Chronic Pancreatitis, Healthy Volunteers | Phase 2 | Completed | Meridian Bioscience, Inc. | 33 | 2009-01-01 | 2022-12-20 |
| Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality Pioglitazone, Placebo - Chronic Pancreatitis, Insulin Resistance | Phase 2 | Completed | University of Michigan | 64 | 2008-11-01 | 2018-01-11 |
| Pain and Chronic Pancreatitis - Clinical End Experimental Studies Pregabalin, placebo - Chronic Pancreatitis | Phase 2 / Phase 3 | Completed | Aalborg University Hospital | 64 | 2008-10-01 | 2010-08-20 |
Pancreatitis, Chronic (14) · Exocrine Pancreatic Insufficiency (2) · Pain (2) · Pancreatitis (2) · Abdominal Pain (1) · Chronic Pain (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Insulin Resistance (1) · Neuralgia (1) · Pancreatic Neoplasms (1) · alpha 1-Antitrypsin Deficiency (1)
Chronic Disease (14) · Digestive System Diseases (14) · Disease Attributes (14) · Pancreatic Diseases (14) · Pathologic Processes (14) · Pathological Conditions, Signs and Symptoms (14) · Pancreatitis (12) · Neurologic Manifestations (3) · Signs and Symptoms (3) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Autoimmune Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Diazepam (1) · Dronabinol (1) · Endoscopy (1) · Hydroxychloroquine (1) · Indomethacin (1) · Pancrelipase (1) · Pioglitazone (1) · Pregabalin (1) · Secretin (1) · Sodium Chloride (1) · Spinal Cord Stimulation (1) · benzoyl-tyrosyl-alanine (1)
Aalborg University Hospital (2) · Medical University of South Carolina (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · AzurRx SAS (1) · ChiRhoClin, Inc. (1) · Children's Hospital of Philadelphia (1) · Kangen Pharmaceuticals, Inc (1) · Mayo Clinic (1) · Meridian Bioscience, Inc. (1) · Radboud University Medical Center (1) · The Cleveland Clinic (1) · University of Michigan (1)
United States (8) · Netherlands (3) · Denmark (2) · Australia (1) · France (1) · India (1) · New Zealand (1) · Russia (1) · Ukraine (1)
Hongjun Wang, Ph.D (2) · Babette Zemel, PhD (1) · Betul Hatipoglu, MD (1) · Harry van Goor, MD PhD (1) · Helga A Gulisano, MD (1) · Marc G. Besselink, MD PhD MSc (1) · Matthew DiMagno, M.D. (1) · Phiip Hart, MD (1) · Santhi Vege, MD (1) · Timothy B Gardner, M.D. (1) · Virginia Stallings, MD (1)
PMID 21848870, PMID 22879908, PMID 23548879, PMID 31412955, PMID 38103842, PMID 38659255, PMID 40622408
R01DK105183 (1), R21AA017271 (1), R21DK117212 (1)